Actinium-225

CAMBRIDGE, Mass., June 2, 2026 Convergent Therapeutics announced positive interim Phase 2 data from its CONVERGE-01 study evaluating CONV01-α...

BOSTON, May 29, 2026 Ratio Therapeutics has expanded its manufacturing collaboration with PharmaLogic Holdings Corp. to support the clinical...

Dublin, Ohio, USA – April 1, 2026 In a significant advancement for the rapidly evolving field of targeted cancer...